Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea · Delayed Price · Currency is KRW 4,580.00
-120.00 (-2.55%)
Jun 11, 2026, 2:20 PM KST
Oncocross Market Cap
Oncocross has a market cap or net worth of 57.32 billion as of June 10, 2026. Its market cap has decreased by -63.85% in one year.
Market Cap
57.32B
Enterprise Value
38.47B
Revenue
475.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
4,580.00
Market Cap Chart
Since December 18, 2024, Oncocross's market cap has decreased from 106.25B to 57.32B, a decrease of -46.05%. That is a compound annual growth rate of -34.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 57.32B | -50.26% |
| Dec 30, 2025 | 115.23B | 53.28% |
| Dec 30, 2024 | 75.18B | -29.24% |
| Dec 18, 2024 | 106.25B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 135.98B |
| MedPacto | 114.14B |
| Vaxcell-Bio Therapeutics | 112.22B |
| ENCell | 94.85B |
| Amicogen | 89.33B |
| GeneOne Life Science | 83.15B |
| iNtRON Biotechnology | 81.09B |
| Prestige BioPharma | 79.33B |